PATENT CLAIM ANALYSIS

Application Number: 16002918
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "184100"]

Abstract:
The present application relates to the use of bacterial minicells as targeted delivery agents in vivo and in vitro. Described herein are genetically engineered eubacterial minicells designed to preferentially target and deliver therapeutically relevant agents using a minicell surface coupling molecule capable of binding and displaying antibodies or other Fc-containing targeting moiety fusions and conjugates.

Claim (Index 33):
The method of  claim 32 , wherein the immuno-modulators are Toll-like receptor agonists or Toll-like receptor antagonists.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 1.1875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13397313', '15425181', '15044403', '11211098', '14152979']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6962779766476381
- 35 USC 102 Novelty (BERT): 0.5775026632641358
- Combined Prediction Score: 0.6844004453092879
- Mean Citation Score: 365.160398
- Max Citation Score: 559.9877299999998
- Similarity Product: 329.69801903327635

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test